By Elyse Andrews
I want to discuss a stock that Cabot had great success with back in 2007 and that has recently reappeared on our radar screens: Crocs (CROX). Way back before the big bear market of 2008 (remember that?), Cabot Market Letter nabbed its subscribers 307% profits in CROX. And recently, the stock popped up in Cabot Top Ten Trader.
I remember clearly the first time I saw someone wearing a pair of Crocs shoes. It was the summer of 2004 and they were bright orange. I thought the shoes were the most ridiculous looking things I’d ever seen. Nevertheless, sales have boomed!
Crocs’ success has come from its lines of sandals, sneakers and other types of shoes made from its proprietary closed-cell resin Croslite material. Crocs makes shoes for men, women and kids in almost every color you can imagine. The company also sells shoes in other materials, like leather, and shoe charms that fit onto its classic clog model.
Hospitals and restaurants are big customers, though most of the people I know who own Crocs just love the convenience factor of having a lightweight, slip-on shoe that cleans easily (probably a big reason for their popularity with kids).
After getting hit hard in the bear market and recession, Crocs is doing well again!
Crocs reported just last week that its second quarter revenues jumped 30% to $296 million and earnings soared 65% to $0.61 per share. The company also saw wholesale sales rise 26% to $176 million, retail sales pop 38% to $92 million and online sales jump 30% to $28 million.
Much of Crocs’ growth is due to its overseas and product line expansion. In Q2, sales in the Americas were up 16% to $121 million, sales in Asia increased 38% to $122 million and sales in Europe climbed 50% to $52 million.
The company increased its forward guidance after the glowing quarter and many analysts followed suit. Shares of CROX jumped last Thursday after the news and subscribers to Cabot Top Ten Trader are sitting on 50% gains since they bought the stock in May.